Drug Type Small molecule drug |
Synonyms 2-(2-hydroxybiphenyl-3-yl)-1H-indole-5-carboxamidine |
Target |
Mechanism uPA inhibitors(Urokinase plasminogen activator inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H17N3O |
InChIKeyGAVRMVQHHVMXFD-UHFFFAOYSA-N |
CAS Registry277312-42-2 |